申请人:K.U. Leuven Research & Development
公开号:US07253176B1
公开(公告)日:2007-08-07
The invention relates to a novel use of 8-substituted xanthine derivatives for the manufacture of a medicament for the treatment of auto-immuno disorders.
这项发明涉及使用8-取代黄嘌呤衍生物制造治疗自身免疫性疾病药物的新方法。